Scalper1 News
NantKwest (NK) soared on its first day of trading, after raising $207 million in an upsized initial public offering. NantKwest is in the hot field of immunotherapy, which deploys the patient’s own immune system to fight cancer and other diseases. NantKwest offered 8.3 million shares at 25 each. The initial plan was to offer 7 million shares at 20 to 23. The stock opened at 37, up 48%. In late morning trading, NantKwest was up 35%, near 33.40, in Scalper1 News
Scalper1 News